Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
US6822001B2 · kind B2 · utility
4Cited by
52References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2001 |
| Grant date | Nov 23, 2004 |
| Priority date | — |
| Expiry date | Nov 2, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent such as gemcitabine or paclitaxel.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.